FDA Proposes Mandatory Asbestos Testing for Talc-Based Cosmetics

The new rule is intended to protect consumers from asbestos exposure in cosmetic products. The U.S. Food and Drug Administration (FDA) recently proposed a rule under the Modernization…

Read More

Federal Court Rules in Favor of Generic Drug Competition in Patent Case

The court orders the removal of improper patent listings, clearing the path for lower-cost medications. The Federal Circuit U.S. Court of Appeals recently upheld a lower court’s decision…

Read More

FDA Approves Medication for Obstructive Sleep Apnea

First OSA drug treatment for obese adults offers new hope alongside diet and exercise. The FDA recently approved Zepbound (tirzepatide) as the first drug treatment for moderate to…

Read More

FDA Approves Medication for Rare Adrenal Gland Disorder

Crenessity reduces glucocorticoid dependency and improves hormone control for classic CAH. The FDA has recently approved Crenessity (crinecerfont) for use alongside glucocorticoids in treating adults and children aged…

Read More

FDA and USDA Seek Public Input on Food Date Labeling to Reduce Waste

Federal agencies seek to clarify “Sell By,” “Use By,” and “Best By” terms to prevent food waste. The U.S. Food and Drug Administration (FDA) and Department of Agriculture…

Read More

FDA Considers Ban of Food Coloring

The move could be made ahead of the incoming administration. The Food and Drug Administration’s (FDA) Deputy Commissioner for Human Foods Jim Jones announced during a Senate meeting…

Read More

Supreme Court Hears Arguments on Flavored E-Cig Regulations

Justices question alleged inconsistencies in the FDA approval process. The Supreme Court heard arguments this week on the regulation of flavored e-cigarettes, reviewing allegations that the Food and…

Read More

FDA Investigates “Forever Chemicals” in Seafood

Officials looking into the public health ramifications of PFAS contamination. The Food and Drug Administration (FDA) opened an investigation last month into the impact of per- and polyfluoroalkyl…

Read More

FDA Recalls Umary Hyaluronic Acid Supplements Sold through Amazon 

One lot number was found to be contaminated with over-the-counter drugs. The Food and Drug Administration (FDA) recently issued a recall on Umary-branded hyaluronic acid supplements, warning that…

Read More

FDA Moves to Eliminate Oral Phenylephrine from OTC Nasal Decongestants

Review finds oral phenylephrine ineffective, leading to a proposal for market removal. The U.S. Food and Drug Administration (FDA) recently proposed removing oral phenylephrine from over-the-counter (OTC) products…

Read More

Back to top
FE3